Mark Cuban Cost Plus Drug Company (MCCPDC) announced a partnership with pharmacy benefit manager RxPreferred Benefits.
The companies said the deal will allow employers and their members using RxPreferred access to MCCPDC medications through their plan.
MCCPDC is a public-benefit corporation and online pharmacy that aims to provide medications at a lower cost by working directly with distributors...
Missouri-based healthcare fintech Paytient announced it had secured $40.5 million in Series B funding, bringing the company's total raise to $63 million. The funds include $33 million in equity from new and existing investors and $7.5 million in debt from Silicon Valley Bank.
Mercato Partners Traverse Fund led the round, with participation from Bertelsmann Investments. Mercato's managing...
Carbon Health announced that the hybrid care provider had received $100 million in Series D investment from CVS Health Ventures days after revealing a second round of layoffs in the past year.
On Friday, Carbon Health's CEO Eren Bali revealed on Twitter the company had laid off more than 200 employees as it shifts focus to its core primary care and urgent care services while "unwinding" its...
Tech-backed chronic kidney disease and end-stage renal disease management company Monogram Health announced it had scored a whopping $375 million in growth funding.
Strategic investors in the round include CVS Health, Humana, SCAN Health Plan, Cigna Ventures and Memorial Hermann Health System. Other participants include First Cressey Ventures, TPG Capital, Pura Vida Investments, Northwest...
Virtual primary and urgent care provider Carbon Health announced another round of layoffs, noting the company is letting go of more than 200 people.
The company's CEO Eren Bali announced the layoffs via Twitter, saying Carbon Health will shift its focus to its core primary care and urgent care services, "unwinding" its programs in public health, remote patient monitoring, hardware and chronic...
New Jersey-based virtual psychiatry and therapy platform Array Behavioral Care scored $25 million in its latest funding round led by CVS Health. Additional capital was provided by existing investors.
CVS Health joins Array's earlier investors in supporting the company, including Wells Fargo Strategic Capital, Harbour Point Capital, Health Velocity Capital, OSF Healthcare, HLM Venture Partners and...
Israeli company liberDi received FDA 510(k) clearance for its Intelligent Dialysis Assistant, accompanying IDA cartridge with a medical supervision portal, and IDA smartphone app.
IDA allows patients to undergo peritoneal dialysis outside of a clinic while being remotely monitored by a medical professional via the device's telemedicine capabilities.
Peritoneal dialysis is one of the two methods...
French health tech company Volta Medical, which developed an AI-enabled software for interventional cardiac electrophysiology, garnered €36 million ($37.8 million) in Series B funding, bringing its total raise to €70 million ($73.6 million).
U.S.-based Vensana Capital led the round, with co-investment from Lightstone Ventures and Glide Healthcare.
Volta offers its FDA-cleared XV1 AI-enabled...
Connected tech company Withings announced the launch of U-Scan, a biomarker assessment platform that can be placed inside a toilet bowl to monitor an individual's health using urine analysis.
U-Scan is a reader with changeable analysis cartridges that analyzes one's urine for specific biomarkers associated and sends insights to the Withings Health Mate app daily.
The device differentiates...
Spero Health's 99 outpatient substance abuse centers will now have access to Pear Therapeutics' reSET and reSET-O prescription digital therapeutics to help treat individuals with substance use disorder and opioid use disorder.
The integrated healthcare services company previously used Pear's prescription digital therapeutics in 14 Kentucky locations. Thanks to the expanded partnership, Spero will...
